NSCLC cells were treated with non-targeting control siRNA and Fas, DR3, DR4, DR5, DR6 siRNA (100 nM) for 24 h, and then were treated with PL (10 μM) for another 24 h. Here, TNFRSF21 is linked to non-small cell lung carcinoma.